Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | KIF11 | P52732 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL301883 | 0.82 | ALDH1A1 (0.79) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| SCHEMBL13087029 | 0.82 | ALDH1A1 (0.79) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| SCHEMBL27234611 | 0.82 | ALDH1A1 (0.79) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| SCHEMBL2109569 | 0.82 | CYP3A4 (0.44) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| Benzidine SCHEMBL720393 | 0.78 | CYP3A4 (1.00) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| SCHEMBL258287 | 0.78 | CYP3A4 (1.00) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| SCHEMBL2024128 | 0.78 | CYP3A4 (1.00) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| SCHEMBL28842081 | 0.78 | CYP3A4 (1.00) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| Benzidine SCHEMBL29021 | 0.78 | CYP3A4 (1.00) | ALDH1A1TDP1CYP3A4TP53HSD17B10 | |
| Benzidine SCHEMBL5140469 | 0.78 | CYP3A4 (1.00) | ALDH1A1TDP1CYP3A4TP53HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4806468-A | Measurement of glycosylated hemoglobin by immunoassay | BECTON, DICKINSON AND COMPANY (US) | 1989-02-21 | — | — | US | claimed |
| CN-119932184-A | Diagnostic reagent and therapeutic reagent for human head and neck squamous carcinoma | 中国科学院昆明动物研究所 | 2025-05-06 | — | — | CN | disclosed |
| CN-114340898-A | Multilayer polyimide film and method for producing same | 聚酰亚胺先端材料有限公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20170160290-A1 | A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION | ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP) (FR) | 2017-06-08 | — | — | US | disclosed |
| EP-3167290-A1 | A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2017-05-17 | — | — | EP | disclosed |
| WO-2016005432-A1 | A NEW BIOMARKER OF CHRONIC ALLOGRAFT NEPHROPATHY AND OF RENAL TRANSPLANT REJECTION | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2016-01-14 | — | — | WO | disclosed |
| US-20150079083-A1 | Alpha B-Crystallin as a Therapy for Ischemia or Inflammation | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2015-03-19 | — | — | US | disclosed |
| US-8835391-B2 | Alpha B-crystallin as a therapy for multiple sclerosis | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-09-16 | — | — | US | disclosed |
| US-8771689-B2 | Alpha B-crystallin as a therapy for ischemia or inflammation | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-07-08 | — | — | US | disclosed |
| US-20110318346-A1 | Alpha B-crystallin as a therapy for Ischemia or inflammation | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2011-12-29 | — | — | US | disclosed |
| US-20110160142-A1 | Alpha B-Crystallin as a therapy for inflammation | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2011-06-30 | — | — | US | disclosed |
| US-7875589-B2 | Alpha B-crystallin as a therapy for rheumatoid arthritis | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2011-01-25 | — | — | US | disclosed |
| CN-101573136-A | Alpha B crystallins as agents for treating inflammation | UNIV LELAND STANFORD JUNIOR (US) | 2009-11-04 | — | — | CN | disclosed |
| EP-2104511-A2 | ALPHA B-CRYSTALLIN AS A THERAPY FOR INFLAMMATION | The Board of Trustees of The Leland Stanford Junior University (US) | 2009-09-30 | — | — | EP | disclosed |
| WO-2008073466-A2 | ALPHA B-CRYSTALLIN AS A THERAPY FOR INFLAMMATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2008-06-19 | — | — | WO | disclosed |
| US-20080138353-A1 | Using chaperone protein to treat and prevention autoimmune and nervous system disorders | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2008-06-12 | — | — | US | disclosed |
| US-4806468-A | Measurement of glycosylated hemoglobin by immunoassay | BECTON, DICKINSON AND COMPANY (US) | 1989-02-21 | — | — | US | disclosed |